| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.44 | 2e-30 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-13 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-11 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-11 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |